Wie hoch ist der Preis für Roche Holding AG (RO)

Preis für Roche Holding AG (RO) ist $481.73

Wie hoch ist die Marktkapitalisierung für Roche Holding AG (RO)

Marktkapitalisierung für Roche Holding AG (RO) ist $377.65B

Roche Holding AG (RO) Dividendenrendite

Roche Holding AG is a global healthcare enterprise with dual focuses: pharmaceuticals and diagnostics. The company maintains a significant presence in numerous countries, including its home base in Switzerland, alongside Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and various other international markets. Its pharmaceutical segment develops and supplies treatments for a wide spectrum of medical conditions, encompassing oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments, as well as specific therapies for anemia, dermatology, hemophilia, inflammatory and autoimmune conditions, and transplant patients. On the diagnostic front, Roche provides in vitro tests designed to identify various diseases like cancer, diabetes, COVID-19, hepatitis, and human papillomavirus, in addition to supplying crucial diagnostic instruments and reagents. The company was founded in Basel, Switzerland, in 1896.

Jahr	Dividendenrendite	ändert
Nicht genügend Daten für die angegebenen Daten.

Jahr

Dividendenrendite

ändert

Nicht genügend Daten für die angegebenen Daten.

Unternehmen	Dividendenrendite	Land
Eli Lilly and Company LLY.US	0.56%	US
Johnson & Johnson JNJ.US	2.04%	US
AbbVie Inc. ABBV.US	2.72%	US
Merck & Co., Inc. MRK.US	2.58%	US
Novartis AG NOVN.SW	2.80%	CH

Unternehmen

Dividendenrendite

Land

Eli Lilly and Company

LLY.US

0.56%

Johnson & Johnson

JNJ.US

2.04%

AbbVie Inc.

ABBV.US

2.72%

Merck & Co., Inc.

MRK.US

2.58%

Novartis AG

NOVN.SW

2.80%

Roche Holding AG

RO

Kategorie